FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1925-1927 May 5, 2005 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Tesfaye, S. PubMed Citation

To the Editor: In the article by Tesfaye et al. (Jan. 27 issue)¹ on the European Diabetes (EURODIAB) Prospective Complications Study, which looked at modifiable risk factors for diabetic neuropathy, the first line of the abstract states, "Other than glycemic control, there are no treatments for diabetic neuropathy." Although there have been no prospective, randomized trials to date, there is a growing literature regarding the role of nerve decompression in carefully selected patients with diabetic distal, large-fiber, symmetric polyneuropathy.

A recent analysis of 50 patients with diabetes who underwent decompression of the tibial and peroneal nerves in one leg and . . . [Full Text of this Article]

This article has been cited by other articles:

• Boulton, A. J.M. (2007). Whither Clinical Research in Diabetic Sensorimotor Peripheral Neuropathy?: Problems of end point selection for clinical trials. Diabetes Care 30: 2752-2753 [Full Text]  
• Sone, H., Tanaka, S., Ishibashi, S., Yamasaki, Y., Oikawa, S., Ito, H., Saito, Y., Ohashi, Y., Akanuma, Y., Yamada, N., for the Japan Diabetes Complications Study (JDCS), (2006). The New Worldwide Definition of Metabolic Syndrome Is Not a Better Diagnostic Predictor of Cardiovascular Disease in Japanese Diabetic Patients Than the Existing Definitions: Additional analysis from the Japan Diabetes Complications Study. Diabetes Care 29: 145-147 [Full Text]